Cargando…

Inflammation-Driven Reprogramming of CD4(+)Foxp3(+) Regulatory T Cells into Pathogenic Th1/Th17 T Effectors Is Abrogated by mTOR Inhibition in vivo

While natural CD4(+)Foxp3(+) regulatory T (nT(REG)) cells have long been viewed as a stable and distinct lineage that is committed to suppressive functions in vivo, recent evidence supporting this notion remains highly controversial. We sought to determine whether Foxp3 expression and the nT(REG) ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yurchenko, Ekaterina, Shio, Marina T., Huang, Tony C., Da Silva Martins, Maria, Szyf, Moshe, Levings, Megan K., Olivier, Martin, Piccirillo, Ciriaco A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335853/ https://www.ncbi.nlm.nih.gov/pubmed/22545118 http://dx.doi.org/10.1371/journal.pone.0035572

Ejemplares similares

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Plasmodium chabaudi AS Infection Induces CD4(+) Th1 Cells and Foxp3(+)T-bet(+) Regulatory T Cells That Express CXCR3 and Migrate to CXCR3 Ligands
por: Berretta, Floriana, et al.
Publicado: (2019)

Reprogramming in vivo th17 into th17/th2 by Sirp-α dendritic cells in the lungs
por: Quang Van, Vu, et al.
Publicado: (2011)

Diversity and flexibility of Th17 effector functions
por: Kamradt, Thomas, et al.
Publicado: (2011)

Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome
por: Xiao, Na, et al.
Publicado: (2022)

Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance
por: Kornete, Mara, et al.
Publicado: (2012)

TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
por: Marwaha, Ashish K., et al.
Publicado: (2012)

Update on regulation and effector functions of Th17 cells
por: Sandquist, Ivy, et al.
Publicado: (2018)

Th1-Like ICOS(+) Foxp3(+) T(reg) Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice
por: Kornete, Mara, et al.
Publicado: (2015)

Ex-Th17 Foxp3+ T cells - a novel subset of Foxp3+ T cells induced in cancer
por: Downs-Canner, Stephanie, et al.
Publicado: (2015)

mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile
por: Hu, Shurong, et al.
Publicado: (2016)

Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
por: Prajeeth, Chittappen K., et al.
Publicado: (2017)

The Imbalance between Foxp3(+)Tregs and Th1/Th17/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis
por: Liang, Ma, et al.
Publicado: (2018)

Regulation of FoxP3(+) Regulatory T Cells and Th17 Cells by Retinoids
por: Kim, Chang H.
Publicado: (2008)

Correction: mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile
por: Hu, Shurong, et al.
Publicado: (2016)

FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions
por: Grover, Payal, et al.
Publicado: (2021)

Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone
por: Mehdi, Ali, et al.
Publicado: (2022)

Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
por: Moon, Jeonghyeon, et al.
Publicado: (2021)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
por: Cummings, Matthew, et al.
Publicado: (2018)

Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment
por: Kornete, Mara, et al.
Publicado: (2013)

Foxp3 Post-translational Modifications and Treg Suppressive Activity
por: Deng, Guoping, et al.
Publicado: (2019)

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
por: Bouamar, Hakim, et al.
Publicado: (2023)

Suppressive IL-17A(+)Foxp3(+) and ex-Th17 IL-17A(neg)Foxp3(+) T(reg) cells are a source of tumour-associated T(reg) cells
por: Downs-Canner, Stephanie, et al.
Publicado: (2017)

BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation
por: Deason, Krystin, et al.
Publicado: (2018)

Mesenchymal Stem Cell Protects Injured Renal Tubular Epithelial Cells by Regulating mTOR-Mediated Th17/Treg Axis
por: Luo, Yongsheng, et al.
Publicado: (2021)

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
por: Moon, Jeonghyeon, et al.
Publicado: (2021)

IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
por: Mailer, Reiner K. W., et al.
Publicado: (2015)

BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
por: Oster, Christoph, et al.
Publicado: (2019)

Human Blood CD1c(+) Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4(+) T Cells
por: Leal Rojas, Ingrid M., et al.
Publicado: (2017)

Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3(+) Treg Development by Galectin-9 Secretion
por: Oomizu, Souichi, et al.
Publicado: (2012)

Th-POK regulates mammary gland lactation through mTOR-SREBP pathway
por: Zhang, Rui, et al.
Publicado: (2018)

Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses
por: Martynova, Ekaterina, et al.
Publicado: (2022)

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
por: Luger, Dror, et al.
Publicado: (2008)

Signaling Through gp130 Compromises Suppressive Function in Human FOXP3(+) Regulatory T Cells
por: Bin Dhuban, Khalid, et al.
Publicado: (2019)

The Metalloprotease ADAM12 Regulates the Effector Function of Human Th17 Cells
por: Zhou, Angela X., et al.
Publicado: (2013)

Boosting NAD: An opportunity for metabolic reprogramming of Th17 cells in psoriatic disease
por: Reali, Eva
Publicado: (2023)

Infected site-restricted Foxp3(+) natural regulatory T cells are specific for microbial antigens
por: Suffia, Isabelle J., et al.
Publicado: (2006)

Pleiotropic Effects of IL-33 on CD4(+) T Cell Differentiation and Effector Functions
por: Alvarez, Fernando, et al.
Publicado: (2019)

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
por: Esfahani, Khashayar, et al.
Publicado: (2019)

IL-2 as a therapeutic target for the restoration of Foxp3(+ )regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease
por: d'Hennezel, Eva, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ih4jfbofb9hh97qolh57amhee